Brief: Iveric Bio Reports Fourth Quarter And Full Year 2022 Operational Highlights And Financial Results
01/03/2023 11:35
March 1 (Reuters) - Iveric Bio Inc ISEE.O :
* IVERIC BIO REPORTS FOURTH QUARTER AND FULL YEAR 2022
OPERATIONAL
HIGHLIGHTS AND FINANCIAL RESULTS
* QTRLY NET LOSS $0.47 PER DILUTED SHARE
* Q4 EARNINGS PER SHARE VIEW $-0.38 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBwz0h10a
Further company coverage: ISEE.O
Recent news on IVERIC bio
See all newsBrief: Astellas Pharma Inc - Astellas Completes Acquisition Of Iveric Bio
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
Iveric Bio Inc Reports Results For The Quarter Ended In March: Earnings Summary
The end of cheap credit could hurry Japanese M&A
U.S. STOCKS ON THE MOVE-US banks, Biomea Fusion, Tutor Perini